Thyroid Gland Disorder Treatment Market Analysis Report By Indication (Hypothyroidism, Hyperthyroidism), By RoA (Oral, Intravenous), By Distribution Channel, And Segment Forecasts, 2018 - 2025

  • ID: 4538755
  • Report
  • 92 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Abbott
  • AbbVie, Inc.
  • Amgen Inc.
  • GlaxoSmithKline plc
  • Lannett Company, Inc.
  • Merck KGaA
  • MORE
The global thyroid gland disorder treatment market size is expected to reach USD 2.6 billion by 2025., and exhibit a 3.2% CAGR during the forecast period. Increase in prevalence of thyroid diseases around the globe is expected to drive demand for anti-thyroid drugs in the coming years. Hypothyroidism is one of the leading causes of hospitalization in U.S. Growing awareness about disease management amongst healthcare professionals and patients is another factor augmenting market growth. There are various private and public organizations working toward spreading awareness related to disease management, such as British Thyroid Foundation,The American Thyroid Association (ATA), and Thyroid Foundation of Canada.

Rising demand for these drugs has resulted in development of various generic equivalents of branded drugs to treat thyroid gland disorders. Generic drug manufacturers are focusing on strategies such as new product development, distribution channel enhancement, regional expansions, and collaborations with other companies for marketing their products to gain an edge over the competition. In addition, regulatory authorities that approve generic versions of branded drugs are working to overcome delays in product approvals and enable the availability of these drugs at a lower price. This is expected to boost the market over the forecast period.

Further key findings from the report suggest:
  • Hypothyroidism held the dominant revenue share in 2016 and is expected to maintain its position throughout the forecast period. On the other hand, hyperthyroidism is expected to witness steady growth on account of increase in incidence of Graves’ disease
  • The oral route is the most preferred or most frequently used route of administration owing to its convenience and simplicity, which helps improve patient compliance. The market is driven by the presence of a strong pipeline of oral anti-thyroid medications
  • Wholesalers accounted for the largest revenue share as of 2016 owing to increasing spending on outpatient prescription drugs along with overall healthcare expenditure. E-commerce is expected to witness lucrative growth in the coming years
  • The U.S. thyroid gland disorder treatment market is anticipated to exceed USD 1.03 billion by 2025 due to presence of sophisticated healthcare infrastructure, increased patient awareness, and high healthcare expenditure and R&D in drug discovery and development
  • Asian countries, especially India and China, are expected to observe remarkable growth in the coming years
  • The market is fragmented in nature, with presence of various large and small pharmaceutical players
  • Some of the key companies in the market areAbbott; AbbVie, Inc.; Merck KGaA; Mylan N.V.; Amgen Inc.; Pfizer, Inc.; GlaxoSmithKline plc.; and Lannett Company, Inc.


PLEASE NOTE:
This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • AbbVie, Inc.
  • Amgen Inc.
  • GlaxoSmithKline plc
  • Lannett Company, Inc.
  • Merck KGaA
  • MORE
Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Research Methodology
2.1 Region Wise Market Calculation
2.1.1 Region wise market: Base estimates
2.1.2 Global market: CAGR calculation
2.2 Research Scope & Assumptions
2.3 List of Data Sources

Chapter 3 Thyroid Gland Disorder Treatment Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Rising incidence of thyroid disease
3.2.2 Collaborations to promote thyroid medications
3.3 Market Restraint Analysis
3.3.1 Generic competition
3.4 Penetration & Growth Prospect Mapping
3.5 Thyroid Gland Disorders Treatment - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s

Chapter 4 Thyroid Gland Disorder Treatment Market: Indication Estimates & Trend Analysis
4.1 Thyroid Gland Disorders Treatment Market: Indication Movement Analysis
4.2 Hypothyroidism
4.2.1 Hypothyroidism market, 2014 - 2025 (USD Million)
4.3 Hyperthyroidism
4.3.1 Hyperthyroidism market, 2014 - 2025 (USD Million)

Chapter 5 Thyroid Gland Disorder Treatment Market: Route of Administration Estimates & Trend Analysis
5.1 Thyroid Gland Disorders Treatment Market: RoA Movement Analysis
5.2 Oral
5.2.1 Oral market, 2014 - 2025 (USD Million)
5.3 Intravenous
5.3.1 Intravenous market, 2014 - 2025 (USD Million)
5.4 Others
5.4.1 Others market, 2014 - 2025 (USD Million)

Chapter 6 Thyroid Gland Disorder Treatment Market: Distribution Channel Estimates & Trend Analysis
6.1 Thyroid Gland Disorders Treatment Market: Distribution Channel Movement Analysis
6.2 Wholesalers/Distributors
6.2.1 Wholesalers/distributors market, 2014 - 2025 (USD Million)
6.3 Retail Chain
6.3.1 Retail chain market, 2014 - 2025 (USD Million)
6.4 Online Distribution
6.4.1 Online distribution market, 2014 - 2025 (USD Million)
6.5 Others
6.5.1 Others market, 2014 - 2025 (USD Million)

Chapter 7 Thyroid Gland Disorder Treatment Market: Regional Estimates & Trend Analysis, by Indication, RoA, and Distribution Channel
7.1 Thyroid Gland Disorders Treatment Market Share by Region, 2016 & 2025
7.2 North America
7.2.1 North America thyroid gland disorders treatment market, by country, 2014 - 2025 (USD Million)
7.2.2 North America thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.2.3 North America thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.2.4 North America thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.2.5 U.S.
7.2.5.1 U.S. thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.2.5.2 U.S. thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.2.5.3 U.S. thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.2.6 Canada
7.2.6.1 Canada thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.2.6.2 Canada thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.2.6.3 Canada thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe thyroid gland disorders treatment market, by country, 2014 - 2025 (USD Million)
7.3.2 Europe thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.3.3 Europe thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.3.4 Europe thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.3.5 U.K.
7.3.5.1 U.K. thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.3.5.2 U.K. thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.3.5.3 U.K. thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.3.6 Germany
7.3.6.1 Germany thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.3.6.2 Germany thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.3.6.3 Germany thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific thyroid gland disorders treatment market, by country, 2014 - 2025 (USD Million)
7.4.2 Asia Pacific thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.4.3 Asia Pacific thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.4.4 Asia Pacific thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.4.5 Japan
7.4.5.1 Japan thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.4.5.2 Japan thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.4.5.3 Japan thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.4.6 China
7.4.6.1 China thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.4.6.2 China thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.4.6.3 China thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.4.7 India
7.4.7.1 India thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.4.7.2 India thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.4.7.3 India thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America thyroid gland disorders treatment market, by country, 2014 - 2025 (USD Million)
7.5.2 Latin America thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.5.3 Latin America thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.5.4 Latin America thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.5.5 Brazil
7.5.5.1 Brazil thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.5.5.2 Brazil thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.5.5.3 Brazil thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.5.6 Mexico
7.5.6.1 Mexico thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.5.6.2 Mexico thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.5.6.3 Mexico thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.6 MEA
7.6.1 MEA thyroid gland disorders treatment market, by country, 2014 - 2025 (USD Million)
7.6.2 MEA thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.6.3 MEA thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.6.4 MEA thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)
7.6.5 South Africa
7.6.5.1 South Africa thyroid gland disorders treatment market, by indication, 2014 - 2025 (USD Million)
7.6.5.2 South Africa thyroid gland disorders treatment market, by RoA, 2014 - 2025 (USD Million)
7.6.5.3 South Africa thyroid gland disorders treatment market, by distribution channel, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Abbott
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 AbbVie, Inc.
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 Merck KGaA
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 Mylan N.V.
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Amgen Inc.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Pfizer, Inc.
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 GlaxoSmithKline plc
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Lannett Company, Inc.
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives

List of Tables

Table. 1 Market summary
Table. 2 Market trends & outlook
Table. 3 Market segmentation & scope
Table. 4 Market driver relevance analysis (Current & future impact)
Table. 5 Market restraint relevance analysis (Current & future impact)
Table. 6 Penetration & growth prospect mapping
Table. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
Table. 8 Porter’s Five Forces Analysis
Table. 9 Thyroid gland disorders treatment market, indication outlook: Key takeaways
Table. 10 Thyroid gland disorders treatment market: Indication movement analysis
Table. 11 Hypothyroidism market, 2014 - 2025 (USD Million)
Table. 12 Hyperthyroidism market, 2014 - 2025 (USD Million)
Table. 13 Thyroid gland disorders treatment market, RoA outlook: Key takeaways
Table. 14 Thyroid gland disorders treatment market: RoA movement analysis
Table. 15 Oral market, 2014 - 2025 (USD Million)
Table. 16 Intravenous market, 2014 - 2025 (USD Million)
Table. 17 Others market, 2014 - 2025 (USD Million)
Table. 18 Thyroid gland disorders treatment market, distribution channel outlook: Key takeaways
Table. 19 Thyroid gland disorders treatment market: Distribution channel movement analysis
Table. 20 Wholesalers/distributors market, 2014 - 2025 (USD Million)
Table. 21 Retail chain market, 2014 - 2025 (USD Million)
Table. 22 Online distribution market, 2014 - 2025 (USD Million)
Table. 23 Others market, 2014 - 2025 (USD Million)
Table. 24 Regional market place: Key takeaways
Table. 25 Regional outlook, 2016 & 2025
Table. 26 North America thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 27 U.S. thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 28 Canada thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 29 Europe thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 30 U.K. thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 31 Germany thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 32 Asia Pacific thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 33 Japan thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 34 China thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 35 India thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 36 Latin America thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 37 Brazil thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 38 Mexico thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 39 MEA thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 40 South Africa thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
Table. 41 Strategy framework
Table. 42 Market participation and categorization

List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Thyroid gland disorders treatment market, indication outlook: Key takeaways
FIG. 10 Thyroid gland disorders treatment market: Indication movement analysis
FIG. 11 Hypothyroidism market, 2014 - 2025 (USD Million)
FIG. 12 Hyperthyroidism market, 2014 - 2025 (USD Million)
FIG. 13 Thyroid gland disorders treatment market, RoA outlook: Key takeaways
FIG. 14 Thyroid gland disorders treatment market: RoA movement analysis
FIG. 15 Oral market, 2014 - 2025 (USD Million)
FIG. 16 Intravenous market, 2014 - 2025 (USD Million)
FIG. 17 Others market, 2014 - 2025 (USD Million)
FIG. 18 Thyroid gland disorders treatment market, distribution channel outlook: Key takeaways
FIG. 19 Thyroid gland disorders treatment market: Distribution channel movement analysis
FIG. 20 Wholesalers/distributors market, 2014 - 2025 (USD Million)
FIG. 21 Retail chain market, 2014 - 2025 (USD Million)
FIG. 22 Online distribution market, 2014 - 2025 (USD Million)
FIG. 23 Others market, 2014 - 2025 (USD Million)
FIG. 24 Regional market place: Key takeaways
FIG. 25 Regional outlook, 2016 & 2025
FIG. 26 North America thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 27 U.S. thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 28 Canada thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 29 Europe thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 30 U.K. thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 31 Germany thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 32 Asia Pacific thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 33 Japan thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 34 China thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 35 India thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 36 Latin America thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 37 Brazil thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 38 Mexico thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 39 MEA thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 40 South Africa thyroid gland disorders treatment market, 2014 - 2025 (USD Million)
FIG. 41 Strategy framework
FIG. 42 Market participation and categorization
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • AbbVie, Inc.
  • Merck KGaA
  • Mylan N.V.
  • Amgen Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Lannett Company, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll